HYPOTHALAMIC OBESITY

Clinical trials for HYPOTHALAMIC OBESITY explained in plain language.

Never miss a new study

Get alerted when new HYPOTHALAMIC OBESITY trials appear

Sign up with your email to follow new studies for HYPOTHALAMIC OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1 Completed 1

Brain injury obesity drug gets extended safety test

Disease control ENROLLING_BY_INVITATION

This study continues testing an experimental drug called bivamelagon for people with obesity caused by damage to a specific brain area (hypothalamus). It follows 25 participants for up to 2 years to check long-term safety and see if the drug helps control weight and improve quali…

Matched conditions: HYPOTHALAMIC OBESITY

Phase: PHASE2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

HYPOTHALAMIC OBESITY

Get alerted when new HYPOTHALAMIC OBESITY trials appear

Brain injury obesity drug gets extended safety test